Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,195
Funds Holding Change
+280
Funds Holding Growth
+6%
Value
$1.39T
Holding in Top 10
966
Top 10 Change
-141
Top 10 Growth
-13%
Value Growth
+1%
New
503
Increased
1,741
Reduced
2,676
Closed
126
Capital Inflow
$38.6B
Capital Outflow
$58.5B
Net Capital Flow
-$19.9B
Capital Flow Change
-$2.47B
Calls
$21B
Puts
$18.6B
Net Calls
+$2.37B
Put/Call Ratio
0.89